Humacyte Inc (HUMA)
6.33
-0.09
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
6.35
+0.02
(+0.32%)
After-Hours: 20:00
Humacyte Shareholders Equity (Quarterly): 26.15M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 26.15M |
December 31, 2023 | 13.55M |
September 30, 2023 | 36.99M |
June 30, 2023 | 61.12M |
March 31, 2023 | 81.89M |
December 31, 2022 | 116.93M |
Date | Value |
---|---|
September 30, 2022 | 118.67M |
June 30, 2022 | 142.26M |
March 31, 2022 | 103.89M |
December 31, 2021 | 122.17M |
September 30, 2021 | 75.86M |
December 31, 2020 | -350.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-350.32M
Minimum
Dec 2020
142.26M
Maximum
Jun 2022
45.76M
Average
78.87M
Median
Shareholders Equity (Quarterly) Benchmarks
Aquestive Therapeutics Inc | -36.30M |
Adial Pharmaceuticals Inc | 4.084M |
Gritstone Bio Inc | 13.96M |
Precision BioSciences Inc | 37.21M |
Puma Biotechnology Inc | 50.98M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 161.47M |
Total Liabilities (Quarterly) | 135.31M |